Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

NCT02441686

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Eastern Maine Medical Center Brewer, Maine, United States
  • Massachusetts General Hosptial Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia

NCT02961218

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Novartis Investigative Site Atlanta, Georgia, United States
  • Novartis Investigative Site Augusta, Georgia, United States
  • Novartis Investigative Site Greenville, North Carolina, United States
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 15 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism

NCT03938454

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Childrens National Hospital Washington D.C., District of Columbia, United States
  • Foundation for Sickle Cell Disease Research Hollywood, Florida, United States
View all 13 locations
View Trial Details
Completed

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

NCT04328727

Conditions
Anemia, Anemia, Aplastic, Bone Marrow Diseases, +4 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Nanchang, Jiangxi, China
  • Novartis Investigative Site Changchun, Jilin, China
View Trial Details
Completed

Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.

NCT05630001

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • City Of Hope National Med Center Duarte, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Lakes Research Miami Lakes, Florida, United States
  • Mass Gen Hosp Cancer Center Boston, Massachusetts, United States
View all 23 locations
View Trial Details
Completed

A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B

NCT05365217

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital-Hematology Fuzhou, Fujian, China
  • Nanfang Hospital, Southern Medical University-Haematology Guangzhou, Guangdong, China
View all 15 locations
View Trial Details

Related conditions